An overview of cell phenotypes in HCS: Limitations and advantages

Expert Opinion on Drug Discovery

Volumn 4, Issue 6, 2009, Pages 643-657

  Gasparri, Fabio ^a  

^a NERVIANO MEDICAL SCIENCES   (Italy)

Author keywords

Cell types; Cell based assays; Drug discovery; High content screening; Imaging

Indexed keywords

2 (3 CYCLOHEXYLALLYL) 3 METHYL 4 QUINOLONE; CELL SPECIFICITY; CELL STRAIN; CELL STRAIN A549; CELL STRAIN BHK; CELL STRAIN HCT116; CELL STRAIN HEK293; CELL STRAIN HEPG2; CELL STRAIN HT29; CELL STRAIN MCF 7; CELL STRAIN U 2 OS; CELL STRUCTURE; CELL TYPE; CHO CELL; FLUORESCENCE IMAGING; HELA CELL; HIGH CONTENT SCREENING; HUMAN; IMAGE ANALYSIS; MOLECULAR RECOGNITION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCREENING;

EID: 67649111551     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460440902992870     Document Type: Review

References (151)

1. Giuliano KA, DeBiasio RL, Dunlay RT, et al. High content screening: a new approach to easing key bottlenecks in the drug discovery process. J Biomol Screen 1997;2:249-259 •• The first article ever defining 'high-content screening' and its principles. (Pubitemid 127690015)
2. Taylor DL. Past, present, and future of high content screening and the field of cellomics. Methods Mol Biol 2007;356:3-18
3. Edwards BS, Oprea T, Prossnitz ER, Sklar LA. Flow cytometry for high-throughput, high-content screening. Curr Opin Chem Biol 2004;8(4):392-398
4. Krutzik PO, Crane JM, Clutter MR, Nolan GP. High-content single-cell drug screening with phosphospecific flow cytometry. Nat Chem Biol 2008;4(2):132-142
5. Minor LK. Label-free cell-based functional assays. Comb Chem High Throughput Screen 2008;11(7):573-580
6. Xi B, Yu N, Wang X, et al. The application of cell-based label-free technology in drug discovery. Biotechnol J 2008;3(4):484-495 (Pubitemid 351618734)
7. Lopez MF, Mikulskis A, Golenko E, et al. High-content proteomics: fluorescence multiplexing using an integrated, high-sensitivity, multiwavelength charge-coupled device imaging system. Proteomics 2003;3(7):1109-1116 (Pubitemid 36929533)
8. Gough AH, Johnston PA. Requirements, features, and performance of high content screening platforms. Methods Mol Biol 2007;356:41-61
9. Dunlay RT, Czekalski WJ, Collins MA. Overview of informatics for high content screening. Methods Mol Biol 2007;356:269-280
10. Giuliano KA, Taylor DL. Fluorescent-protein biosensors: new tools for drug discovery. Trends Biotechnol 1998;16(3):135-140 (Pubitemid 28123107)
11. Giuliano KA, Taylor DL, Waggoner AS. Reagents to measure and manipulate cell functions. Methods Mol Biol 2007;356:141-163
12. Rausch O. High content cellular screening. Curr Opin Chem Biol 2006;10(4):316-320 (Pubitemid 44137295)
13. Krausz E. High-content siRNA screening. Mol Biosyst 2007;3(4):232-240 (Pubitemid 46456307)
14. Gasparri F, Sola F, Bandiera T, et al. High-content analysis of kinase activity in cells. Comb Chem High Throughput Screen 2008;11(7):523-536
15. Dragunow M. High-content analysis in neuroscience. Nat Rev Neurosci 2008;9(10):779-788
16. O'Brien P, Haskins JR. In vitro cytotoxicity assessment. Methods Mol Biol 2007;356:415-425
17. Ding GJF, Fischer PA, Boltz RC, et al. Characterization and quantitation of NF-κB nuclear translocation induced by Interleukin-1 and Tumor Necrosis Factor-α. J Biol Chem 1998;273(44):28897-28905 •• This paper describes for the first time the application of HCS to the analysis of nuclear translocation of a transcription factor (NF-κB).
18. Minguez JM, Giuliano KA, Balachandran R, et al. Synthesis and high content cell-based profiling of simplified analogues of the microtubule stabilizer (+)-discodermolide. Mol Cancer Ther 2002;1(14):1305-13 • In this article a four-colour HCS assay is described for the first time.
19. Giuliano KA. High-content profiling of drug-drug interactions: cellular targets involved in the modulation of microtubule drug action by the antifungal ketoconazole. J Biomol Screen 2003;8(2):125-135 (Pubitemid 40503615)
20. Liebel U, Starkuviene V, Erfle H, et al. A microscope-based screening platform for large-scale functional protein analysis in intact cells. FEBS Lett 2003;554:394-398 (Pubitemid 37412520)
21. Vogt A, Cooley KA, Brisson M, et al. Cell-active dual specificity phosphatase inhibitors identified by high-content screening. Chem Biol 2003;10(8):733-742 (Pubitemid 37089848)
22. Abraham VC, Taylor DL, Haskins JR. High content screening applied to large-scale cell biology. Trends Biotechnol 2004;22(1):15-22 (Pubitemid 38030316)
23. Conrad C, Erfle H, Warnat P, et al. Automatic identification of subcellular phenotypes on human cell arrays. Genome Res 2004;14(6):1130-1136 (Pubitemid 38811549)
24. Ghosh RN, Grove L, Lapets O. A quantitative cell-based high-content screening assay for the epidermal growth factor receptor-specific activation of mitogen-activated protein kinase. Assay Drug Dev Technol 2004;2(5):473-481 (Pubitemid 39619090)
25. Lövborg H, Nygren P, Larsson R. Multiparametric evaluation of apoptosis: effects of standard cytotoxic agents and the cyanoguanidine CHS 828. Mol Cancer Ther 2004;3(5):521-526 (Pubitemid 39193730)
26. Perlman ZE, Slack MD, Feng Y, et al. Multidimensional drug profiling by automated microscopy. Science 2004;306:1194-1198 •• One of the most exhaustive examples of compound mechanism of action profiling by high content analysis. (Pubitemid 39489001)
27. Starkuviene V, Liebel U, Simpson JC, et al. High-content screening microscopy identifies novel proteins with a putative role in secretory membrane traffic. Genome Res 2004;14(10A):1948-1956 (Pubitemid 39386509)
28. Bertelsen M, Sanfridson A. Inflammatory pathway analysis using a high content screening platform. Assay Drug Dev Technol 2005;3(3):261-271 (Pubitemid 41079124)
29. Giuliano KA, Cheung WS, Curran DP, et al. Systems cell biology knowledge created from high content screening. Assay Drug Dev Technol 2005;3(5):501-513 • This paper reports a methodology to measure phenotypic response obtained from multiplexed HCS assays coupled to cell distribution maps and 2D-Kolmogorov-Smirnov analysis to visualize the data generated. (Pubitemid 41824368)
30. Carpenter AE, Jones TR, Lamprecht MR, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 2006;7(10):R100 (Pubitemid 46453508)
31. Fryknäs M, Rickardson L, Wickström M, et al. Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model. J Biomol Screen 2006;11(5):457-468 (Pubitemid 44222997)
32. Neumann B, Held M, Liebel U, et al. High-throughput RNAi screening by time-lapse imaging of live human cells. Nat Methods 2006;3(5):385-390 • This article describes automated high-content time lapse imaging to analyse the phenotype induced by siRNA-mediated downregulation of selected genes, introducing the timing and sequence of cellular events as parameters for phenotyping.
33. Nickischer D, Laethem C, Trask OJ Jr, et al. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling of kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation. Methods Enzymol 2006;414:389-418 (Pubitemid 44716234)
34. Trask OJ Jr, Baker A, Williams RG, et al. Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform. Methods Enzymol 2006;414:419-439 (Pubitemid 44716235)
35. Vassal E, Barette C, Fonrose X, et al. Miniaturization and validation of a sensitive multiparametric cell-based assay for the concomitant detection of microtubule-destabilizing and microtubule-stabilizing agents. J Biomol Screen 2006;11(4):377-389 (Pubitemid 43846338)
36. Williams RG, Kandasamy R, Nickischer D, et al. Generation and characterization of a stable MK2-EGFP cell line and subsequent development of a high-content imaging assay on the Cellomics ArrayScan platform to screen for p38 mitogen-activated protein kinase inhibitors. Methods Enzymol 2006;414:364-389 (Pubitemid 44716233)
37. Kwon YJ, Genovesio A, Youl Kim N, et al. High-content classification of nucleocytoplasmic import or export inhibitors. J Biomol Screen 2007;12(5):621-627 (Pubitemid 47231228)
38. Low J, Huang S, Dowless M, et al. High-content imaging analysis of knockdown effects of validated siRNAs and antisense oligonucleotides. J Biomol Screen 2007;12(6):775-788 (Pubitemid 47340698)
39. Loo L-H, Wu LF, Altschuler SJ. Image-based multivariate profiling of drug responses from single cells. Nat Methods 2007;4(5):445-453 • This article describes a procedure to reduce multidimensional HCS data to human-interpretable phenotypic profiling. (Pubitemid 46901279)
40. Park KM, Kang E, Jeon YJ, et al. Identification of novel regulators of apoptosis using a high-throughput cell-based screen. Mol Cells 2007;23(2):170-174 (Pubitemid 46711677)
41. Prigozhina NL, Zhong L, Hunter EA, et al. Plasma membrane assays and three-compartment image cytometry for high content screening. Assay Drug Dev Technol 2007;5(1):29-48 (Pubitemid 46581239)
42. Simpson JC, Cetin C, Erfle H, et al. An RNAi screening platform to identify secretion machinery in mammalian cells. J Biotechnol 2007;129:352-365 (Pubitemid 46529026)
43. Tao CY, Hoyt J, Feng Y. A support vector machine classifier for recognizing mitotic subphases using high-content screening data. J Biomol Screen 2007;12(4):490-496 (Pubitemid 46871833)
44. Vogt A, Lazo JS. Implementation of high-content assay for inhibitors of mitogen-activated protein kinase phosphatases. Methods 2007;42(3):268-277 (Pubitemid 46805143)
45. Wang J, Xie X. Development of a quantitative, cell-based, high-content screening assay for epidermal growth factor receptor modulators. Acta Pharmacol Sin 2007;28(10):1698-1704 (Pubitemid 47493290)
46. Au Q, Kanchanastit P, Barber JR, et al. High-content image-based screening for small-molecule chaperone amplifiers in heat shock. J Biomol Screen 2008;13(10):953-959
47. Denner P, Schmalowsky J, Prechtl S. High-content analysis in preclinical drug discovery. Comb Chem High Throughput Screen 2008;11:216-230
48. Low J, Huang S, Blosser W, et al. High-content imaging characterization of cell cycle therapeutics through in vitro and in vivo subpopulation analysis. Mol Cancer Ther 2008;7(8):2455-63 •• A paper showing in vitro and in vivo individual cellular sub-population analysis to determine cell-cycle phenotypes induced by chemotherapeutic agents.
49. Raccor BS, Vogt A, Sikorski RP, et al. Cell-based and biochemical structure-activity analyses of analogs of the microtubule stabilizer dictyostatin. Mol Pharmacol 2008;73(3):718-726
50. Sakaue-Sawano A, Kurokawa H, Morimura T, et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 2008;132:487-498 (Pubitemid 351191996)
51. Shi J, Orth JD, Mitchison T. Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5. Cancer Res 2008;68(9):3269-3276 • This study describes a comparative HCS analysis of mitosis and apoptosis induction in eleven human cell lines treated with paclitaxel.
52. Szafran AT, Szwarc M, Marcelli M, Mancini MA. Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects. PLoS ONE 2008;3(11):e3605
53. Young DW, Bender A, Hoyt J, et al. Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat Chem Biol 2008;4(1):59-68 •• This article describes the integration of phenotypic information deriving from HCS with chemical similarity profiling to investigate SAR and predict compound targets. (Pubitemid 350273652)
54. Zhang B, Gu X, Uppalapati U, et al. High-content flluorescent-based assay for screening activators of DNA damage checkpoint pathways. J Biomol Screen 2008;13(6):538-543 (Pubitemid 351905076)
55. Kau TR, Schroeder F, Ramaswamy S, et al. A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. Cancer Cell 2003;4:463-476 (Pubitemid 38050043)
56. Almholt DL, Loechel F, Nielsen SJ, et al. Nuclear export inhibitors and kinase inhibitors identified using a MAPK-activated protein kinase2 redistribution(R) screening. Assay Drug Dev Technol 2004;2(1):7-20 (Pubitemid 38647412)
57. Ghosh RN, DeBiasio R, Hudson CC, et al. Quantitative cell-based high-content screening for vasopressin receptor agonists using transfluor technology. J Biomol Screen 2005;10(5):476-484 (Pubitemid 41233226)
58. Harada JN, Bower KE, Orth AP, et al. Identification of novel mammalian growth regulatory factors by genome-scale quantitative image analysis. Genome Res 2005;15(8):1136-1144 (Pubitemid 41126869)
59. Lundholt BK, Linde V, Loechel F, et al. Identification of Akt pathway inhibitors using redistribution screening on the FLIPR and the IN Cell 3000 Analyzer. J Biomol Screen 2005;10(1):20-29 (Pubitemid 40503506)
60. Auld DS, Johnson RL, Zhang Y-Q, et al. Fluorescent protein-based cellular assays analyzed by laser-scanning microplate cytometry in 1536-well plate format. Methods Enzymol 2006;414:566-589 • A report which illustrates for the first time the application of microplate laser-scanning cytometry to highthroughput high-content screening in 1536-well plates. (Pubitemid 44716241)
61. Duan Z, Bradner JE, Greenberg E, et al. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation. Clin Cancer Res 2006;12(22):6844-6852 (Pubitemid 44876855)
62. Garippa RJ, Hoffman AF, Gradl G, Kirsch A. High-throughput confocal microscopy for beta-arrestin-green fluorescent protein translocation G protein-coupled receptor assays using the Evotec Opera. Methods Enzymol 2006;414:99-120 (Pubitemid 44716219)
63. Gasparri F, Cappella P, Galvani A. Multiparametric cell cycle analysis by automated microscopy. J Biomol Screen 2006;11(6):586-598 (Pubitemid 44315956)
64. Grånäs C, Lundholt BK, Loechel F, et al. Identification of RAS-mitogen-activated protein kinase signaling pathway modulators in an ERF1 redistribution(R) screen. J Biomol Screen 2006;11(4):423-34 •• This article reports an EGFP-ERF1 redistribution screening of one of the largest compound libraries published to date in HCS literature (265,623 compounds). (Pubitemid 43846343)
65. Howell BJ, Lee S, Sepp-Lorenzino L. Development and implementation of multiplexed cell-based imaging assays. Methods Enzymol 2006;414:284-300 (Pubitemid 44716228)
66. Hudson CC, Oakley RH, Sjaastad MD, Loomis CR. High-content screening of known G protein-coupled receptors by arrestin translocation. Methods Enzymol 2006;414:63-78 (Pubitemid 44716217)
67. Oakley RH, Hudson CC, Sjaastad MD, Loomis CR. The ligand-independent translocation assay: an enabling technology for screening orphan G protein-coupled receptors by arrestin recruitment. Methods Enzymol 2006;414:50-63 (Pubitemid 44716216)
68. Soncini C, Carpinelli P, Gianellini L, et al. PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activity. Clin Cancer Res 2006;12(13):4080-4089 (Pubitemid 44078096)
69. Gasparri F, Ciavolella A, Galvani A. Cell-cycle inhibitor profiling by high-content analysis. Adv Exp Med Biol 2007;604:137-148
70. Loechel F, Bjørn S, Linde V, et al. High content translocation assays for pathway profiling. Methods Mol Biol 2007;356:401-414 •• This review summarizes the set-up and application of HCS assays (known as 'redistribution assays') in which the quantitation of the subcellular translocation of a target protein provides the primary readout.
71. Zanella F, Rosado A, Blanco F, et al. An HTS approach to screen for antagonists of the nuclear export machinery using high content cell-based assays. Assay Drug Dev Technol 2007;5(3):333-341 (Pubitemid 47067879)
72. Cappella P, Gasparri F, Pulici M, Moll J. A novel method based on click chemistry, which overcomes limitations of cell cycle analysis by classical determination of BrdU incorporation, allowing multiplex antibody staining. Cytometry A 2008;73(7):626-636 (Pubitemid 351930749)
73. Ross DA, Lee S, Reiser V, et al. Multiplexed assays by high-content imaging for assessment of GPCR activity. J Biomol Screen 2008;13(6):449-455 (Pubitemid 351905074)
74. Simonen M, Ibig-Rehm Y, Hofmann G, et al. High-content assay to study protein prenylation. J Biomol Screen 2008;13(6):456-467 (Pubitemid 351905077)
75. Zanella F, Rosado A, Garcìa B, et al. Chemical genetic analysis of FOXO nuclear-cytoplasmic shuttling by using image-based cell screening. Chembiochem 2008;9(14):2229-2237
76. Conway BR, Minor LK, Xu JZ, et al. Quantification of G-protein coupled receptor internalization using G-protein coupled receptor green fluorescent protein conjugate with the arrayscan high content screening system. J Biomol Screen 1999;4:75-86 (Pubitemid 29278955)
77. Fowler A, Seifert N, Acker V, et al. A nonradioactive high-throughput/high-content assay for measurement of the human serotonin reuptake transporter function in vitro. J Biomol Screen 2006;11(8):1027-1034 (Pubitemid 44847157)
78. MacDonald ML, Lamerdin J, Owens S, et al. Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat Chem Biol 2006;2(6):329-337 •• This paper demonstrates the usefulness of high-content protein-fragment complementation assays to identify novel, unpredicted mechanisms of drug actions. (Pubitemid 43787215)
79. Michnick SW, MacDonald ML, Westwick JK. Chemical genetic strategies to delineate MAP kinase signaling pathways using protein-fragment complementation assays (PCA). Methods 2006;40:287-293 (Pubitemid 44754745)
80. Teusch N, Kiefer C. A high-content screening assay for the Nogo receptor based on cellular Rho activation. Assay Drug Dev Technol 2006;4(2):133-141 (Pubitemid 43810917)
81. Chan EYW, Kir S, Tooze SA. siRNA screening of the kinome identifies ULK1 as a multidomain modulator of autophagy. J Biol Chem 2007;282(35):25464-25474 (Pubitemid 47372826)
82. Rickardson L, Wickström M, Larsson R, Lövborg H. Image-based screening for the identification of novel proteasome inhibitors. J Biomol Screen 2007;12(2):203-210 (Pubitemid 46364423)
83. Trzcinska-Daneluti A, Ly D, Huynh L, et al. High-content functional screen to identify proteins that correct F508del-CFTR function. Mol Cell Proteomics 2009;8(4):780-790
84. Bhawe KM, Blake RA, Clary DO, Flanagan PM. An automated image capture and quantitation approach to identify proteins affecting tumor cell proliferation. J Biomol Screen 2004;9(3):216-222 (Pubitemid 40503552)
85. Giuliano KA, Chen Y-T, Lansing Taylor D. High-content screening with siRNA optimizes a cell biological approach to drug discovery: defining the role of p53 activation in the cellular response to anticancer drugs. J Biomol Screen 2004;9(7):557-568 •• It is described for the first time the coupling of HCS compound profiling and siRNA to study the influence of the genetic background (siRNA-mediated p53 downregulation) on cellular responses to compounds. (Pubitemid 40503514)
86. Tanaka M, Bateman R, Rauh D, et al. An unbiased cell morphology-based screen for new, biologically active small molecules. PLoS Biol 2005;3(5):764-776
87. Grove LE, Ghosh RN. Quantitative characterization of mitosis-blocked tetraploid cells using high content analysis. Assay Drug Dev Technol 2006;4(4):421-442 (Pubitemid 44781633)
88. Smellie A, Wilson C, Ng SC. Visualization and interpretation of high content screening data. J Chem Inf Model 2006;46:201-207
89. Wilson CJ, Si Y, Thompson CM, et al. Identification of a small molecule that induces mitotic arrest using a simplified high-content screening assay and data analysis method. J Biomol Screen 2006;11(1):21-28 • This article reports a high-content high-throughput screening to identify mitotic blockers using a simple DNA stain and describes the implementation of a Kolmogorov-Smirnov (KS) test in high-throughput compound screen. (Pubitemid 43255778)
90. Perlman ZE, Mitchison TJ, Mayer TU. High-content screening and profiling of drug activity in an automated centrosome-duplication assay. ChemBiochem 2005;6(1):145-151 (Pubitemid 40128647)
91. Haasen D, Schnapp A, Valler MJ, Heilker R. G protein-coupled receptor internalization assays in the high-content screening format. Methods Enzymol 2006;414:121-139 (Pubitemid 44716220)
92. Kawai A, Takano S, Nakamura N, Ohkuma S. Quantitative monitoring of autophagic degradation. Biochem Biophys Res Commun 2006;351(1):71-77 (Pubitemid 44635408)
93. Lundholt BK, Heydorn A, Bjørn SP, Praestegaard M. A simple cell-based HTS assay system to screen for inhibitors of p53-Hdm2 protein-protein interactions. Assay Drug Dev Technol 2006;4(6):679-688 (Pubitemid 46218165)
94. Wolff M, Haasen D, Merk S, et al. Automated high content screening for phosphoinositide 3 kinase inhibition using an AKT1 redistribution assay. Comb Chem High Throughput Screen 2006;9:339-350 (Pubitemid 43830727)
95. Esposito A, Dohm CP, Bähr M, Wouters FS. Unsupervised fluorescence lifetime imaging microscopy for high content and high throughput screening. Mol Cell Proteomics 2007;6(8):1446-1454 (Pubitemid 47365442)
96. Haasen D, Merk S, Seither P, et al. Pharmacological profiling of chemochine receptor-directed compounds using high-content screening. J Biomol Screen 2008;13(1):40-53
97. Zhao X, Jones A, Olson KR, et al. A homogeneous enzyme fragment complementation-based beta-arrestin translocation assay for high-throughput screening of G-protein-coupled receptors. J Biomol Screen 2008;13(8):737-747
98. Pollice AA, Smith CA, Brown K, et al. Multiparameter analysis of human epithelial tumor cell lines by laser scanning cytometry. Cytometry 2000;42:347-356 • One of the earliest examples of application of laser scanning cytometry to performing multiparameter fluorescence measurements of individual cells, including suspension cell types. (Pubitemid 32047564)
99. DeBernardi MA, Brooker G. High-content kinetic calcium imaging in drug-sensitive and drug-resistant human breast cancer cells. Methods Enzymol 2006;414:317-335 (Pubitemid 44716230)
100. Liu D, Wang L, Zhong R, et al. Parallel microfluidic networks for studying cellular response to chemical modulation. J Biotechnol 2007;131(3):286-292 (Pubitemid 47362422)
101. Abraham VC, Samson B, Lapets O, Haskins JR. Automated classification of individual cellular responses across multiple targets. Preclinica 2004;2(5):349-355
102. O'Brien PJ, Irwin W, Diaz D, et al. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol 2006;80(9):580-604 •• This article proves the effectiveness of HCS in predicting drug-induced human hepatotoxicity, supporting the in vitro toxicology approach in drug discovery. (Pubitemid 44214526)
103. Ye N, Qin J, Shi W, et al. Cell-based high content screening using an integrated microfluidic device. Lab Chip 2007;7(12):1696-1704 (Pubitemid 350145540)
104. Abraham VC, Towne DL, Waring JF, et al. Application of a high-content multiparameter cytotoxicity assay to prioritize compounds based on toxicity potential in humans. J Biomol Screen 2008;13(6):527-537 (Pubitemid 351905075)
105. Takanaga H, Chaudhuri B, Frommer WB. GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor. Biochim Biophys Acta 2008;1778(4):1091-1099
106. Tencza SB, Sipe MA. Detection and classification of threat agents via high-content assays of mammalian cells. J Appl Toxicol 2004;24:371-377 (Pubitemid 39409919)
107. Barabasz A, Foley B, Otto JC, et al. The use of high-content screening for the discovery and characterization of compounds that modulate mitotic index and cell cycle progression by differing mechanisms of action. Assay Drug Dev Technol 2006;4(2):153-163 (Pubitemid 43810919)
108. Ross S, Chen T, Yu V, et al. High-content screening analysis of the p38 pathway: profiling of structurally related p38alpha kinase inhibitors using cell-based assays. Assay Drug Dev Technol 2006;4(4):397-409 (Pubitemid 44781631)
109. Poon SSS, Wong JT, Sauders DN, et al. Intensity calibration and automated cell cycle gating for high-throughput image-based siRNA screens of mammalian cells. Cytometry A 2008;73(10):904-917
110. Moffat J, Grueneberg DA, Yang X, et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006;124:1283-1298
111. Dürr O, Duval F, Nichols A, et al. Robust hit identification by quality assurance and multivariate data analysis of a high-content, cell-based assay. J Biomol Screen 2007;12(8):1042-1049 (Pubitemid 350179703)
112. Laketa V, Simpson JC, Bechtel S, et al. High-content microscopy identifies new neurite out growth regulators. Mol Biol Cell 2007;18:242-252 (Pubitemid 46066724)
113. Gorjup E, Peter L, Wien S, et al. Automated microscopic quantification of adipogenic differentiation of human gland stem cells. Ann Anat 2009;191(1):13-22
114. Cheong R, Wang CJ, Levchenko A. High-content cell screening in a microfluidic device. Mol Cell Proteomics 2009;8:433-442 • This paper describes a microfluidic device useful to measuring temporal signalling responses in a high-throughput and high-content manner.
115. Morelli JK, Buehrle M, Pognan F, et al. Validation of an in vitro screen for phospholipidosis using a high-content biology platform. Cell Biol Toxicol 2006;22(1):15-27 (Pubitemid 43207806)
116. Wagner BK, Carrinski HA, Ahn YH, et al. Small-molecule fluorophores to detect cell-state switching in the context of high-throughput screening. J Am Chem Soc 2008;130(13):4208-4209
117. Dragunow M, Cameron R, Narayan P, O'Carroll S. Image-based high-throughput quantification of cellular fat accumulation. J Biomol Screen 2007;12(7):999-1005 (Pubitemid 47548593)
118. Martinez ED, Dull AB, Beutler JA, Hager GL. High-content fluorescence-based screening for epigenetic modulators. Methods Enzymol 2006;414:21-36 (Pubitemid 44716214)
119. Li Z, Yan Y, Powers EA, et al. Identification of gap junction blockers using automated fluorescence microscopy imaging. J Biomol Screen 2003;8(5):489-99 •• This paper reports the high-throughput high-content screening of a large chemical library (486,000 compounds) in search of blockers of calcein dye movement through gap junctions overexpressed on cell surface membranes. (Pubitemid 40503581)
120. Evans GJ, Cousin MA. Simultaneous monitoring of three key neuronal functions in primary neuronal cultures. J Neurosci Methods 2007;160(2):197-205 (Pubitemid 46251565)
121. Yarrow JC, Perlman ZE, Westwood NJ, Mitchison TJ. A high-throughput cell migration assay using scratch wound healing, a comparison of image-based readout methods. BMC Biotechnol 2004;4:21 (Pubitemid 40195466)
122. Yarrow JC, Totsukawa G, Charras GT, Mitchison TJ. Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor. Chem Biol 2005;12(3):385-395 (Pubitemid 40406285)
123. Agler M, Prack M, Zhu Y, et al. A high-content glucocorticoid receptor translocation assay for compound mechanism-of-action evaluation. J Biomol Screen 2007;12(8):1029-1041 (Pubitemid 350179704)
124. Wang J, Zhou X, Bradley PL, et al. Cellular phenotype recognition for high-content RNA interference genome-wide screening. J Biomol Screen 2008;13(1):29-39
125. Jensen NA, Gerth K, Grotjohann T, et al. Establishment of a high content assay for the identification and characterization of bioactivities in crude bacterial extracts that interfere with the eukaryotic cell cycle. J Biotechnol 2009;140(1-2):124-134
126. Carpenter AE, Jones TR, Lamprecht MR, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 2006;7(10):R100 (Pubitemid 46453508)
127. Hill AA, LaPan P, Li Y, Haney S. Impact of image segmentation on high-content screening data quality for SK-BR-3 cells. BMC Bioinformatics 2007;8:340 (Pubitemid 350131380)
128. To K, Zhao Y, Jiang H, et al. The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptor. Mol Pharmacol 2007;72(3):641-652 (Pubitemid 47347299)
129. Li F, Zhou X, Zhu J, et al. High content image analysis for human H4 neuroglioma cells exposed to CuO nanoparticles. BMC Biotechnol 2007;7:66
130. Richards GR, Jack AD, Platts A, Simpson PB. Measurement and analysis of calcium signaling in heterogeneous cell cultures. Methods Enzymol 2006;414:335-347 (Pubitemid 44716231)
131. Richards GR, Smith AJ, Parry F, et al. A morphology- and kinetics-based cascade for human neural cell high content screening. Assay Drug Dev Technol 2006;4(2):143-152 (Pubitemid 43810918)
132. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37(3):614-636
133. Gasparri F, Mariani M, Sola F, Galvani A. Quantification of the proliferation index of human dermal fibroblast cultures with the ArrayScanTM high-content screening reader. J Biomol Screen 2004;9(3):232-243 (Pubitemid 40503554)
134. Borchert KM, Galvin RJ, Frolik CA, et al. High-content screening assay for activators of the Wnt/Fzd pathway in primary human cells. Assay Drug Dev Technol 2005;3(2):133-141 (Pubitemid 40846883)
135. Wolf M, Kauschke SG, Schmidt S, Heilker R. Activation and translocation of glucokinase in rat primary hepatocytes monitored by high content image analysis. J Biomol Screen 2008;13(9):837-846
136. Viero C, Kraushaar U, Ruppenthal S, et al. A primary culture system for sustained expression of a calcium sensor in preserved adult rat ventricular myocytes. Cell Calcium 2008;43(1):59-71
137. Pouton CW, Haynes JM. Embryonic stem cells as a source of models for drug discovery. Nat Rev Drug Discov 2007;6(8):605-616 (Pubitemid 47202486)
138. Peerani R, Rao BM, Bauwens C, et al. Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J 2007;26(22):4744-4755 (Pubitemid 350126801)
139. Walker E, Ohishi M, Davey RE, et al. Prediction and testing of novel transcriptional networks regulating embryonic stem cell self-renewal and commitment. Cell Stem Cell 2007;1(1):71-86 (Pubitemid 46865803)
140. Rodriguez RA, Alfonso J, O'Day C, et al. 297 distinct cell lines: a high-content analysis assay and a full-automation design solely using noncontact liquid dispensing. JALA 2007;12:318-326 • A technical report which demonstrates the feasibility of high-content analysis screens using hundreds of cell lines in parallel. (Pubitemid 47382656)
141. Giaccone G, Gadzar AF, Beck H, et al. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression. Cancer Res 1992;52:1666-1674
142. Vasudevan C, Fursov N, Maunder P, et al. Improving high-content-screening assay performance by using division-arrested cells. Assay Drug Dev Technol 2005;3(5):515-523 (Pubitemid 41824369)
143. Digan ME, Pou C, Niu H, Zhang J-H. Evaluation of division-arrested cells for cell-based high-throughput screening and profiling. J Biomol Screen 2005;10(6):615-623 •• Articles [142] and [143] discuss the benefits and shortcomings deriving from the use of division-arrested cell cultures for HCS assays. (Pubitemid 41306660)
144. Lundholt BK, Scudder KM, Pagliaro L. A simple technique for reducing edge effect in cell-based assays. J Biomol Screen 2003;8:566-570 (Pubitemid 40503589)
145. Kanda T, Sullivan KF, Wahl GM. Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr Biol 1998;8(7):377-385 (Pubitemid 28173996)
146. Diaz D, Scott A, Carmichael P, et al. Evaluation of an automated in vitro micronucleus assay in CHO-K1 cells. Mutat Res 2007;630(1-2):1-13 (Pubitemid 46756387)
147. Li F, Zhou X, Ma J, Wong ST. An automated feedback system with the hybrid model of scoring and classification for solving over-segmentation problems in RNAi high content screening. J Microsc 2007;226:121-132 (Pubitemid 46625280)
148. Harder N, Eils R, Rohr K. Automated classification of mitotic phenotypes of human cells using fluorescent proteins. Methods Cell Biol 2008;85:539-554
149. Available from: http://www.lgcstandards-atcc.org/
150. Masters JR. HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer 2002;2(4):315-319 (Pubitemid 37336517)
151. Nardone RM. Eradication of cross-contaminated cell lines: a call for action. Cell Biol Toxicol 2007;23(6):367-72 •• A 'white paper' which denounces the diffuse usage of misidentified and cross-contaminated cell cultures and calls for a global action.